Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

BACKGROUND: Single measurements of plasma Aβ are not useful in the diagnostics of Alzheimer's disease (AD). However, changes in plasma Aβ levels during repeated testing may be helpful in the prediction and evaluation of progression of the incipient AD or mild cognitive impairment. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Seppälä, T T, Herukka, S-K, Hänninen, T, Tervo, S, Hallikainen, M, Soininen, H, Pirttilä, T
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976614/
https://www.ncbi.nlm.nih.gov/pubmed/20478847
http://dx.doi.org/10.1136/jnnp.2010.205757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976614/
https://www.ncbi.nlm.nih.gov/pubmed/20478847
http://dx.doi.org/10.1136/jnnp.2010.205757

Ejemplares similares